Cannova Medical

Bio-delivery System for Cannabinoids and Natural Active Ingredients

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Series A Har Adar Founded 2019
LinkedIn
Total raised
$5.3M
Last: Series A 2019-06
Stage
Series A
Founded
2019
Headcount
3
HQ
Har Adar
Sector
Health Tech & Life Sciences

About

Cannova is developing an alternative method for cannabis consumption in the form of a sublingual strip. The sublingual strips are infused with cannabis molecules that are produced using a patent-protected process involving the combination of various formulations with water-soluble cannabinoids and natural active ingredients. The sublingual strip allows producers to more effectively control dosage quantities and significantly increases the effect of the cannabis, allowing it to be used for a variety of purposes including pain management, concentration, as an antidepressant, and to support better sleep.

Additionally, Cannova is developing the NovaJet Pro (“NovaJet”), an innovative, counter-top machine that enables clients to create customized film strips at the convenience of their homes, in real time. With the NovaJet, clients will be able to receive accurate and tailored sublingual strips with specific measured quantities of cannabinoids and other natural substances, customized to their unique demand

Funding history · 2 rounds · $5.3M total

2019-06
Series A $5.0M
2019-01
Seed $250K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Materials & SubstancesRaw Materials
Target customers
ConsumersRecreational & LifestyleCannabisHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

nutraceuticalschronic-patientscannabismedical-cannabistreatmentspain-reliefbiotechnologylife-sciencespharmaceuticalsdrug-deliverywellness